Synlogic (SYBX) Stock Chart & Stock Price History → Bill Gates is all about this tiny $2 stock (From Timothy Sykes) (Ad) Free SYBX Stock Alerts $1.68 +0.03 (+1.82%) (As of 09:54 AM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Synlogic Stock Price Performance5 Day Performance-2.33%1 Month Performance-10.16%3 Month Performance-8.20%6 Month Performance-19.23%Year-To-Date Performance-56.36%1 Year Performance-80.33% Receive SYBX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Synlogic and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Timothy SykesBill Gates is all about this tiny $2 stockWhat does Bill Gates know about this tiny company that we don’t? From the outside, it looks like a worthless $2 stock…>>Click here to discover why Bill Gates is all about this tiny $2 stock. SYBX Stock Chart for Monday, May, 20, 2024 SYBX Chart by TradingView Synlogic Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$1.68$1.65-1.79%$1.72$1.6510,283 shs$19.32 million05/16/2024$1.72$1.68-2.33%$1.77$1.686,233 shs$19.54 million05/15/2024$1.75$1.72-1.71%$1.82$1.65131,498 shs$20.00 million05/14/2024$1.80$1.75-2.78%$1.78$1.7582,566 shs$20.35 million05/13/2024$1.79$1.80+0.56%$1.84$1.782,681 shs$20.93 million05/10/2024$1.83$1.79-2.19%$1.83$1.797,123 shs$20.81 million Get the Latest News and Ratings for SYBX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Synlogic and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$1.87$1.83-2.14%$1.88$1.826,680 shs$21.28 million05/08/2024$1.84$1.87+1.63%$1.87$1.823,474 shs$21.75 million05/07/2024$1.84$1.84$1.89$1.843,385 shs$21.40 million05/06/2024$1.84$1.84$1.91$1.8213,763 shs$21.40 million05/03/2024$1.88$1.84-2.13%$1.90$1.8129,923 shs$21.40 million05/02/2024$1.90$1.88-1.05%$1.89$1.806,055 shs$21.86 million05/01/2024$1.79$1.90+6.15%$1.90$1.807,712 shs$22.14 million04/30/2024$1.87$1.79-4.28%$1.85$1.7820,569 shs$20.85 million04/29/2024$1.87$1.87$1.95$1.828,133 shs$21.78 million04/26/2024$1.89$1.87-1.06%$1.88$1.843,845 shs$21.79 million04/25/2024$1.88$1.89+0.53%$1.90$1.854,043 shs$22.02 million04/24/2024$1.91$1.88-1.57%$1.91$1.8718,900 shs$21.90 million04/23/2024$1.84$1.91+3.80%$1.96$1.8566,030 shs$22.25 million04/22/2024$1.87$1.84-1.60%$1.94$1.7921,725 shs$21.44 million04/19/2024$1.83$1.87+2.19%$1.89$1.7854,373 shs$21.79 million04/18/2024$1.77$1.83+3.39%$1.87$1.7270,279 shs$21.32 million04/17/2024$1.80$1.77-1.67%$1.82$1.7340,036 shs$20.62 million04/16/2024$1.80$1.80$1.82$1.7127,183 shs$20.97 million04/15/2024$1.77$1.80+1.69%$1.83$1.7138,023 shs$20.97 million04/12/2024$1.75$1.76+0.57%$1.80$1.7119,095 shs$20.50 million04/11/2024$1.80$1.75-2.78%$1.85$1.7552,718 shs$20.38 million04/10/2024$1.80$1.80$1.82$1.7344,971 shs$20.97 million04/09/2024$1.76$1.80+2.27%$1.83$1.716,897 shs$20.97 million04/08/2024$1.78$1.76-1.12%$1.77$1.718,078 shs$20.50 million04/05/2024$1.79$1.78-0.56%$1.79$1.718,329 shs$20.74 million04/04/2024$1.79$1.79$1.89$1.7415,038 shs$20.85 million04/03/2024$1.76$1.79+1.70%$1.86$1.7371,781 shs$20.85 million04/02/2024$1.76$1.76$1.76$1.7053,815 shs$20.50 million04/01/2024$1.79$1.76-1.68%$1.79$1.7319,600 shs$20.50 million03/29/2024$1.79$1.79$1.85$1.7043,940 shs$20.85 million03/28/2024$1.78$1.79+0.56%$1.85$1.7043,940 shs$20.85 million03/27/2024$1.78$1.78$1.78$1.733,111 shs$20.74 million03/26/2024$1.80$1.78-1.11%$1.78$1.7316,711 shs$20.74 million03/25/2024$1.80$1.80$1.80$1.7331,703 shs$20.97 millionEverybody laughed when he recommended Netflix (Ad)"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade.03/22/2024$1.75$1.80+2.86%$1.80$1.73126,531 shs$20.97 million03/21/2024$1.73$1.75+1.16%$1.81$1.7037,006 shs$16.08 million03/20/2024$1.78$1.73-2.81%$1.82$1.70210,269 shs$15.90 million03/19/2024$1.90$1.78-6.32%$2.04$1.76113,088 shs$16.36 million03/18/2024$1.85$1.90+2.70%$1.97$1.8137,023 shs$17.46 million03/15/2024$1.79$1.85+3.35%$1.85$1.7717,492 shs$17.00 million03/14/2024$1.86$1.79-3.76%$1.89$1.7371,350 shs$16.45 million03/13/2024$1.88$1.86-1.06%$1.92$1.8113,871 shs$17.09 million03/12/2024$1.85$1.88+1.62%$1.92$1.8322,930 shs$17.28 million03/11/2024$1.83$1.85+1.09%$1.91$1.7980,653 shs$17.00 million03/08/2024$1.80$1.83+1.67%$1.89$1.8055,135 shs$16.82 million03/07/2024$1.85$1.80-2.70%$1.91$1.8092,870 shs$16.54 million03/06/2024$1.84$1.85+0.54%$1.90$1.7712,286 shs$17.00 million03/05/2024$1.81$1.84+1.66%$1.86$1.7723,638 shs$16.91 million03/04/2024$1.86$1.81-2.69%$1.89$1.7359,664 shs$16.63 million03/01/2024$1.91$1.86-2.62%$1.94$1.8620,428 shs$17.09 million02/29/2024$1.87$1.91+2.14%$1.98$1.8725,454 shs$17.55 million02/28/2024$1.89$1.87-1.06%$1.91$1.8621,706 shs$17.19 million02/27/2024$1.91$1.89-1.05%$1.95$1.8033,189 shs$17.37 million02/26/2024$1.91$1.91$1.95$1.8621,953 shs$17.55 million02/23/2024$1.95$1.91-2.05%$1.96$1.7956,833 shs$17.55 million02/22/2024$1.97$1.95-1.02%$2.16$1.93111,988 shs$17.92 million02/21/2024$1.83$1.97+7.65%$2.07$1.76108,981 shs$18.10 million02/20/2024$1.81$1.83+1.39%$1.84$1.7543,646 shs$16.82 million02/19/2024$1.81$1.81$1.90$1.7263,300 shs$16.59 million Related Companies: Alaunos Therapeutics Stock Chart Lumos Pharma Stock Chart BioVie Stock Chart Orgenesis Stock Chart NeuroBo Pharmaceuticals Stock Chart KALA BIO Stock Chart MEI Pharma Stock Chart Cocrystal Pharma Stock Chart Benitec Biopharma Stock Chart Indaptus Therapeutics Stock Chart Receive SYBX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Synlogic and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SYBX) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Gold4 Cryptos BETTER than BitcoinTrue Market InsidersDoes this make you sick?Allegiance GoldBill Gates is all about this tiny $2 stockTimothy SykesUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synlogic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.